Garty M, Ben-Zvi Z, Hurwitz A
J Pharmacol Exp Ther. 1985 Aug;234(2):391-4.
Morphine sulfate, 20 mg/kg, or equivalent doses of the opioids, meperidine and fentanyl, elevated plasma levels of lidocaine after i.v. administration of this antiarrhythmic drug. Plasma levels of the lidocaine metabolites, monoethylglycinexylidine and glycinexylidine, were reduced by opioids as lidocaine levels were elevated. The opioid antagonist, naloxone, 1 mg/kg, reversed the effects of morphine, 20 mg/kg, on lidocaine. After morphine, plasma levels of both lidocaine and indocyanine green were elevated, suggesting that the effect of morphine on lidocaine disposition was related to reduced hepatic blood flow. Morphine and meperidine increased lethality of i.v. lidocaine, as shown by marked reduction of LD50 by either opioid.
静脉注射抗心律失常药物利多卡因后,20毫克/千克的硫酸吗啡或等效剂量的阿片类药物哌替啶和芬太尼可提高利多卡因的血浆水平。随着利多卡因水平升高,阿片类药物可降低利多卡因代谢产物单乙基甘氨酰二甲苯胺和甘氨酰二甲苯胺的血浆水平。1毫克/千克的阿片类拮抗剂纳洛酮可逆转20毫克/千克吗啡对利多卡因的作用。注射吗啡后,利多卡因和吲哚菁绿的血浆水平均升高,表明吗啡对利多卡因处置的影响与肝血流量减少有关。吗啡和哌替啶可增加静脉注射利多卡因的致死率,如任一阿片类药物均可显著降低其半数致死量所示。